Altered Fc galactosylation in IgG(4) is a potential serum marker for chronic lung disease

Characterising chronic lung diseases is challenging. New, less invasive diagnostics are needed to decipher disease pathologies and subphenotypes. Fc galactosylation is known to affect IgG function, and is altered in autoimmune disorders and under other pathological conditions. We tested how well Fc...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyder, Tina, Wiklundh, Emil, Eklund, Anders, James, Anna, Grunewald, Johan, Zubarev, Roman A., Lundström, Susanna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066530/
https://www.ncbi.nlm.nih.gov/pubmed/30083550
http://dx.doi.org/10.1183/23120541.00033-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066530/
https://www.ncbi.nlm.nih.gov/pubmed/30083550
http://dx.doi.org/10.1183/23120541.00033-2018

Ejemplares similares